This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 27 Nov 2017  |  North America  |  Mega Trends

    Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

    New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

    Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

    $4,950.00
  2. 30 Jun 2017  |  Europe  |  Mega Trends

    Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

    Data-driven Solutions and Co-development are Key Growth Drivers

    The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...

    $4,950.00
  3. 19 Jun 2017  |  Asia Pacific  |  Mega Trends

    Growth Opportunities in the APAC IVD Market, Forecast to 2021

    Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

    The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...

    $4,950.00
  4. 31 May 2017  |  Europe  |  Mega Trends

    Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021

    Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth

    The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...

    $4,950.00
  5. 23 May 2017  |  North America  |  Mega Trends

    Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

    US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation

    The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...

    $4,950.00
  6. 29 Mar 2017  |  Europe  |  Mega Trends

    Biosimilars Market, Europe, Forecast to 2025

    A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter

    Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

    $4,950.00
  7. 02 Feb 2017  |  Europe  |  Mega Trends

    European Next-generation Sequencing Services Market, Forecast to 2023

    Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

    The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...

    $4,950.00